ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,386Medicare Part D Prescriptions Filled, Including Refills

Rank: 185 out of 680

$624K Total Retail Price of All Prescriptions

Rank: 203 out of 680

477 Patients Receiving at Least One Drug in Part D
46%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 477 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

5% of this provider’s 5,843 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
TRAMADOL HCL 447 210 1 18
FUROSEMIDE 338 185 2 6
NEXIUM 307 111 3 16
METOPROLOL TARTRATE 281 140 4 12
POTASSIUM CHLORIDE 266 139 5 14
METFORMIN HCL 263 162 6 8
LISINOPRIL 261 118 7 5
HYDROCHLOROTHIAZIDE 246 93 8 9
OMEPRAZOLE 244 144 9 7
METOPROLOL SUCCINATE 213 140 10 13
GABAPENTIN 206 90 11 15
AMITRIPTYLINE HCL 201 93 R 12 47
CLOPIDOGREL 185 107 13 26
AMLODIPINE BESYLATE 180 96 14 1
LISINOPRIL-HYDROCHLOROTHIAZIDE 164 80 15 37
CYCLOBENZAPRINE HCL 158 52 R 16 81
MELOXICAM 152 80 17 24
ETODOLAC 144 65 18 206
SIMVASTATIN 144 83 18 3
LEVOTHYROXINE SODIUM 144 85 18 2
PLAVIX 143 86 21 39
CLOTRIMAZOLE-BETAMETHASONE 133 76 22 138
ATENOLOL 132 53 23 19
CYMBALTA 116 57 24 46
QUETIAPINE FUMARATE 110 48 25 64
DIOVAN HCT 108 75 26 55
ISOSORBIDE MONONITRATE ER 104 75 27 59
DOXYCYCLINE HYCLATE 99 45 28 95
KLOR-CON M20 96 43 29 61
ATORVASTATIN CALCIUM 95 48 30 11
MIRTAZAPINE 93 39 31 78
PANTOPRAZOLE SODIUM 90 30 32 30
DIOVAN 85 40 33 31
PRAVASTATIN SODIUM 84 58 34 10
CLONIDINE HCL 81 49 35 36
GLIPIZIDE 78 55 36 63
CRESTOR 76 44 37 25
COMBIVENT 75 29 38 168
TRIAMTERENE-HCTZ 74 49 39 52
PROAIR HFA 73 22 40 67
SEROQUEL 73 38 40 123
AMOXICILLIN 70 22 42 111
CARVEDILOL 69 38 43 23
METHOCARBAMOL 67 20 R 44 251
LYRICA 66 37 45 77
ENALAPRIL MALEATE 66 21 45 65
NAPROXEN 64 23 47 121
INSULIN SYRINGE 63 30 48 86
SPIRONOLACTONE 60 11 49 82
ESCITALOPRAM OXALATE 60 0 49 45
METHYLPREDNISOLONE 59 26 51 93
DONEPEZIL HCL 59 59 51 27
HYDROCODONE-ACETAMINOPHEN 57 45 S3 53 4
FAMOTIDINE 56 33 54 89
TAMSULOSIN HCL 56 44 54 34
PREMARIN 56 22 R 54 105
PHENYTOIN SODIUM EXTENDED 56 35 54 115
CIPROFLOXACIN HCL 51 13 58 57
MEGESTROL ACETATE 50 40 R 59 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 3, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.